Your browser doesn't support javascript.
loading
Feasibility and early clinical impact of precision medicine for late-stage cancer patients in a regional public academic hospital.
Ladekarl, Morten; Nøhr, Anne Krogh; Sønderkær, Mads; Dahl, Simon Christian; Sunde, Lone; Vestereghem, Charles; Mapendano, Christophe Kamungu; Haslund, Charlotte Aaquist; Pagh, Anja; Carus, Andreas; Lörincz, Tamás; Nowicka-Matus, Kinga; Poulsen, Laurids Ø; Laursen, René Johannes; Dybkær, Karen; Poulsen, Birgitte Klindt; Frøkjær, Jens Brøndum; Brügmann, Anja Høegh; Ernst, Anja; Wanders, Alkwin; Bøgsted, Martin; Pedersen, Inge Søkilde.
Affiliation
  • Ladekarl M; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Nøhr AK; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Sønderkær M; Center for Clinical Data Science, Aalborg University and Aalborg University Hospital, Aalborg, Denmark.
  • Dahl SC; Center for Molecular Prediction of Inflammatory Bowel Disease (PREDICT), Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Sunde L; Molecular Diagnostics and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Vestereghem C; Center for Clinical Data Science, Aalborg University and Aalborg University Hospital, Aalborg, Denmark.
  • Mapendano CK; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Haslund CA; Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
  • Pagh A; Center for Clinical Data Science, Aalborg University and Aalborg University Hospital, Aalborg, Denmark.
  • Carus A; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Lörincz T; Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.
  • Nowicka-Matus K; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Poulsen LØ; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Laursen RJ; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Dybkær K; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Poulsen BK; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Frøkjær JB; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Brügmann AH; Department of Oncology and Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.
  • Ernst A; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Wanders A; Department of Neurosurgery, Aalborg University Hospital, Aalborg, Denmark.
  • Bøgsted M; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
  • Pedersen IS; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
Acta Oncol ; 62(3): 261-271, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36905645
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Precision Medicine Type of study: Guideline / Prognostic_studies Limits: Humans / Male Language: En Year: 2023 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Precision Medicine Type of study: Guideline / Prognostic_studies Limits: Humans / Male Language: En Year: 2023 Type: Article